VORGEFÜLLTE EINWEGINJEKTIONSVORRICHTUNG

European patent · EP2911724 · In force

Register entry

Publication number
EP2911724
Application number
EP13779859
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 22, 2013
Published
Sep 2, 2015
Granted
Jul 19, 2017
Protection ends at the latest
Oct 21, 2033
Next annual fee due
Oct 31, 2026
IPC classes
A61M 5/32 (2006.01)
Priority
EP 12189993 25.10.2012
US 201261720623 P 31.10.2012
PCT application
PCT/EP2013/072064 22.10.2013
PCT publication
WO2014/064100 01.05.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Jul 19, 2017

    Granted

    Published in Swissreg on 19.07.2017

Parties

Holder

Novo Nordisk A/S

Novo Allé, 2880 Bagsværd, DK

Inventor

BENGTSSON, Henrik

DK-2880 Bagsværd, DK

STEFANSEN, Mads Schenstrøm

DK-2880 Bagsværd, DK

EILERTSEN, Lars

DK-2880 Bagsværd, DK

GRÅSKOV, Henning

DK-2880 Bagsværd, DK

MOSER, Claus

DK-2860 Søborg, DK

BJARNSHOLT, Thomas

DK-2860 Søborg, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.